Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mei-Dan Ying"'
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e98973 (2014)
Osteosarcoma, one of the most common malignant bone tumours, is generally considered a differentiation disease caused by genetic and epigenetic disruptions in the terminal differentiation of osteoblasts. Novel therapies based on the non-cytotoxic ind
Externí odkaz:
https://doaj.org/article/40899db963054898a8ac5a1240c664a5
Autor:
Min, He, Jia-Bin, Cai, Can, Lai, Jun-Qing, Mao, Jie-Ni, Xiong, Zhong-Hai, Guan, Lin-Jie, Li, Qiang, Shu, Mei-Dan, Ying, Jin-Hu, Wang
Publikováno v:
World Journal of Clinical Cases. 10:6437-6445
Undifferentiated embryonal sarcoma of the liver (UESL) is a rare and aggressive mesenchymal tumor in children. Herein, we describe our experience in neoadjuvant therapy (NAT) and subsequent surgery for the treatment of UESL in children.To evaluate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed556d0039b1d0465b7a9b73a8f58bad
https://doi.org/10.12998/wjcc.v10.i19.6437
https://doi.org/10.12998/wjcc.v10.i19.6437
Autor:
Hong Zhu, Bo Yang, Qiao-Jun He, Hui Zhang, Ying-Hui Sun, Yong Peng, Yong-Xin Han, Pei-Hua Luo, Jian Ma, Ji Cao, Mei-Dan Ying, Xiao-Yang Dai, Fang-Jie Yan, Zi-Bo Chen, Ying Chen, Dan-Dan Wang
Hepatocellular carcinoma is among the leading causes of cancer-related deaths worldwide, and the development of new treatment regimens is urgently needed to improve therapeutic approach. In our study, we found that the combination of a Met inhibitor,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93a8acbb44b4e6f572bdbccfc050ceb1
https://doi.org/10.1158/1535-7163.c.6538797
https://doi.org/10.1158/1535-7163.c.6538797
Autor:
Hong Zhu, Bo Yang, Qiao-Jun He, Hui Zhang, Ying-Hui Sun, Yong Peng, Yong-Xin Han, Pei-Hua Luo, Jian Ma, Ji Cao, Mei-Dan Ying, Xiao-Yang Dai, Fang-Jie Yan, Zi-Bo Chen, Ying Chen, Dan-Dan Wang
The combination of cabozantinib and CT-707 imposed minimal synergistic cytotoxicity against the human hepatocyte HL-7702 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd21e8a98b02c525e6b5e928f4bb4aa
https://doi.org/10.1158/1535-7163.22507818
https://doi.org/10.1158/1535-7163.22507818
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2018)
Ferroptosis is a process driven by accumulated iron-dependent lipid ROS that leads to cell death, which is a distinct regulated cell death comparing to other cell death. The lethal metabolic imbalance resulted from GSH depletion or inactivation of gl
Externí odkaz:
https://doaj.org/article/935e724ee91b4a91825c9498cdff8557
Autor:
Yi-fan Chen, Run-zhi Liu, Wen-wen Ying, Yue-ning Yang, Sen-feng Xiang, Xue-jing Shao, Ji Cao, Yan-qi Zhang, Bo Yang, Qiao-jun He, Mei-dan Ying
Publikováno v:
Acta pharmacologica Sinica.
Neddylation is a type of posttranslational protein modification that has been observed to be overactivated in various cancers. UBC12 is one of two key E2 enzymes in the neddylation pathway. Reports indicate that UBC12 deficiency may suppress lung can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b389a94fa5f1a81cb17f0086a41c78bb
https://pubmed.ncbi.nlm.nih.gov/36138144
https://pubmed.ncbi.nlm.nih.gov/36138144
Publikováno v:
Acta pharmacologica Sinica.
Gastrointestinal tumors have become a worldwide health problem with high morbidity and poor clinical outcomes. Chemotherapy and surgery, the main treatment methods, are still far from meeting the treatment needs of patients, and targeted therapy is i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2667898c49b2171b06ebe2874f012cf2
https://pubmed.ncbi.nlm.nih.gov/36266566
https://pubmed.ncbi.nlm.nih.gov/36266566
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 8 (2018)
Frontiers in Pharmacology, Vol 8 (2018)
Ferroptosis is a process driven by accumulated iron-dependent lipid ROS that leads to cell death, which is a distinct regulated cell death comparing to other cell death. The lethal metabolic imbalance resulted from GSH depletion or inactivation of gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::641d05e875cb69e233790d1205f114ed
Publikováno v:
Frontiers in Pharmacology; 3/14/2017, Vol. 8, p1-9, 9p